TrialJAMA oncology2020

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.

Tessa G Steenbruggen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.